Antleron

Antleron is an R&D company specialized in bespoke cell and gene therapy product and bioprocess modelling, wet lab research & development, and clinical & industrial translation. Antleron’s hybrid bioprocess development platform enables faster, more affordable, and more equitable delivery of cell and gene therapies to patients by integrating scalable, closed and automated bioreactors with AI-driven digital-twins. From discovery to process development and CMC, Antleron’s smart scale-down model service combines custom, lab-scale, modular bioreactors with its Nexus-driven digital twin platform to predict, develop and optimize clinical-scale bioprocesses and manufacturing systems. Antleron’s CellGuide® fixed-bed upstream bioreactor platform completes its smart scale-down model offering by enabling improved quality, consistency and scalability from lab to patient for bespoke therapies.